How Biogen cut batch exceptions 70% to make Alzheimer's care cheaper

Pharmaceutical manufacturers face growing pressure to scale production while cutting costs — a critical challenge when lives are at stake. For companies developing treatments like those for Alzheimer's, balancing affordability, quality, and volume demands rethinking how operational data informs decisions.

This case study shows how a global biopharmaceutical company used real-time data integration to transform production, achieving:

• 50% faster test result times
• 70% fewer batch exceptions
• Real-time, event-driven process corrections

Read the full case study to see how integrating operational data with advanced controls improves pharmaceutical manufacturing.